AbbVie
ABBV
#30
Rank
NZ$555.36 B
Marketcap
$314.27
Share price
0.92%
Change (1 day)
27.68%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of September 2024 : NZ$10.76 Billion

According to AbbVie's latest financial reports the company has NZ$10.76 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$NZ$16.44 B-39.62%
2022-12-31$NZ$27.22 B20.48%
2021-12-31$NZ$22.59 B24.5%
2020-12-31$NZ$18.15 B-249.59%
2019-12-31$-NZ$12.14 Billion-3.63%
2018-12-31$-NZ$12.6 Billion-275.45%
2017-12-31$NZ$7.17 B7.23%
2016-12-31$NZ$6.69 B16.11%
2015-12-31$NZ$5.76 B159.25%
2014-12-31$NZ$2.22 B-59.33%
2013-12-31$NZ$5.46 B33.71%
2012-12-31$NZ$4.08 B-73.26%
2011-12-31$NZ$15.28 B-24.89%
2010-12-31$NZ$20.35 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NZ$164.16 B 1,424.59%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$30.50 B 183.31%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$25.39 B 135.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$13.34 B 23.98%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$32.61 B 202.92%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$29.01 B 169.46%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$31.93 B 196.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$72.37 B 572.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$4.82 B-55.21%๐Ÿ‡บ๐Ÿ‡ธ USA